USPH vs MD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 26, 2026

USPH

52.7
AI Score
VS
MD Wins

MD

53.2
AI Score

Investment Advisor Scores

USPH

53score
Recommendation
HOLD

MD

53score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric USPH MD Winner
Forward P/E 27.027 8.2102 MD
PEG Ratio 2.7047 0.2433 MD
Revenue Growth 7.9% 3.9% USPH
Earnings Growth 23.6% 50.0% MD
Tradestie Score 52.7/100 53.2/100 MD
Profit Margin 4.4% 9.0% MD
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

USPH 1M: +10.9% · 3M: +11.0% MD 1M: +1.4% · 3M: +17.8%

Current Technical Phase

USPH

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.1% over 20 days), RSI 67

RSI (14): 66.8 · Price: $79.06

MD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.9% over 20 days), RSI 57

RSI (14): 57.0 · Price: $26.51

Fundamentals Snapshot

Metric USPH MD
Market Cap
Forward P/E 23.2 11.3
Trailing P/E 160.3 12.7
Revenue (TTM)
Revenue Growth 0.1% 0.0%
Gross Margin 0.2% 0.3%
Operating Margin 0.1% 0.1%
EPS 0.50 2.12
Dividend Yield 0.02%

Frequently Asked Questions

Based on our detailed analysis, MD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.